antiplatelet agent

antiplatelet agent

[-plat′lit]
therapeutic agent that inhibits platelet function. Often employed to prevent clot propagation or secondary thrombosis in patients who have had a primary arterial thrombolytic event such as acute myocardial infarction, peripheral artery disease, or cerebrovascular accident.

antiplatelet agent

Therapeutics Any agent–eg, aspirin, that ↓ platelet clumping and clotting

an·ti·plate·let a·gent

(an'tē-plāt'lĕt ā'jĕnt)
Agent that inhibits platelet aggregation and thus reduces the risk of thrombus formation.
References in periodicals archive ?
Again, for patients who had additional bleeding risk factors, but were not taking an antiplatelet agent or NSAID, PPI therapy showed no statistically significant effect.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), today announced the results of Phase 3 clinical trials in Japan of the antiplatelet agent prasugrel hydrochloride (hereafter, prasugrel) for ischemic cerebrovascular disease patients.
When a patient is on an anticoagulant or antiplatelet agent, it takes longer for primary hemostasis to occur; subsequently bleeding time is prolonged.
25) Doses of aspirin >320mg/day may decrease the effectiveness as antiplatelet agent due to inhibition of prostacyclin production.
The new intravenous antiplatelet agent adds to the firm's commercial offerings in the cardiac cath lab.
The use of an antiplatelet agent is recommended to decrease the risk of recurrent stroke.
It proposed a clinical response to Clopidogrel, an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease.
In this sub analysis for a new antiplatelet agent, this combination therapy did not prove to be useful, on the contrary, it produced more harm.
Ticagrelor: A Novel Reversible Oral Antiplatelet Agent.
In about two-thirds of those hospitalizations, the drug or drug class responsible for the event was warfarin, an antiplatelet agent, insulin, or an oral hypoglycemic agent, and the adverse reaction was either bleeding or hypoglycemia.
1) Aspirin, a salicylate, is the most commonly used over-the-counter (OTC) antiplatelet agent, taken at either an 81 mg dose for cardioprevention or a full-strength dose of 325 mg.